Merck Serono, part of Germany-based pharmaceutical company Merck, has opened a technology incubator in Israel. Merck Serono has committed to investing at least €10m ($13m) by 2018, according to Merck Serono’s website. Merck Serono added: "The bioincubator offers both seed financing and access to dedicated, state-of-the-art laboratory facilities within Inter-Lab, Merck Serono’s Israel-based research and…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
